Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

18

Revenue 2014

Astellas

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Astellas' 2013 sales performance.

Can NICE deliver on its funding promises?

Can NICE deliver on its funding promises?

What started with a positive recommendation last January for Astellas’Xtandi in prostate cancer has certainly provided much work for the industry too.

Astellas names Linda Friedman as EVP, general counsel

Astellas names Linda Friedman as EVP, general counsel Astellas names Linda Friedman as EVP, general counsel. She is due to take up the role on 1 April. ... HBA). Hatanaka said: “ For nearly 24 years, Linda has played a formative role in the evolution of Astellas. “

Lilly claims first place for JAK inhibitor Olumiant in EU

Lilly claims first place for JAK inhibitor Olumiant in EU Other JAK inhibitors in late-stage development for RA that could reach the market in the next couple of years include Galapagos/Gilead Sciences' filgotinib, AbbVie's ABT-494 and Astellas'

AZ, FibroGen's anaemia drug on course for first filing this year

AZ, FibroGen's anaemia drug on course for first filing this year Astellas has commercialisation rights in Japan.

AbbVie takes anti-tau drug into phase II for Alzheimer's

AbbVie takes anti-tau drug into phase II for Alzheimer's and Astellas.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health4Brands

At H4B, we are an energetic new team with fresh ideas, but we have over 275 years of combined experience...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics